Mar 20 |
Harrow, Inc. 2023 Q4 - Results - Earnings Call Presentation
|
Mar 20 |
Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
|
Mar 20 |
Harrow Health Non-GAAP EPS of -$0.20 misses by $0.15, revenue of $36.36M misses by $1.5M
|
Mar 19 |
Harrow Inc (HROW) Reports Substantial Revenue Growth Amidst Net Loss Expansion in 2023
|
Mar 19 |
Harrow Announces Fourth Quarter and Year-End 2023 Financial Results
|
Mar 19 |
Harrow: Q4 Earnings Insights
|
Mar 18 |
Harrow Health Q4 2023 Earnings Preview
|
Mar 13 |
Harrow (HROW) Fell on Lowering the Guidance
|
Mar 5 |
Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024
|
Feb 21 |
Here’s How Harrow (HROW) Weighed on SRK Capital’s Performance
|